These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 17540583

  • 21. Exploratory behaviour of rats in the elevated plus-maze is differentially sensitive to inactivation of the basolateral and central amygdaloid nuclei.
    Moreira CM, Masson S, Carvalho MC, Brandão ML.
    Brain Res Bull; 2007 Mar 15; 71(5):466-74. PubMed ID: 17259015
    [Abstract] [Full Text] [Related]

  • 22. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA.
    J Pharmacol Exp Ther; 2007 Dec 15; 323(3):838-45. PubMed ID: 17823306
    [Abstract] [Full Text] [Related]

  • 23. Nicotine-induced anxiogenic-like behaviours of rats in the elevated plus-maze: possible role of NMDA receptors of the central amygdala.
    Zarrindast MR, Aghamohammadi-Sereshki A, Rezayof A, Rostami P.
    J Psychopharmacol; 2012 Apr 15; 26(4):555-63. PubMed ID: 21948937
    [Abstract] [Full Text] [Related]

  • 24. Age-related qualitative shift in emotional behaviour: paradoxical findings after re-exposure of rats in the elevated-plus maze.
    Bessa JM, Oliveira M, Cerqueira JJ, Almeida OF, Sousa N.
    Behav Brain Res; 2005 Jul 01; 162(1):135-42. PubMed ID: 15922074
    [Abstract] [Full Text] [Related]

  • 25. Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze.
    Cornélio AM, Nunes-de-Souza RL.
    Behav Brain Res; 2007 Mar 12; 178(1):82-9. PubMed ID: 17207863
    [Abstract] [Full Text] [Related]

  • 26. Protein synthesis in dorsal hippocampus supports the drug tolerance induced by prior elevated plus-maze experience.
    Gazarini L, Stern CA, Bertoglio LJ.
    Neuroscience; 2011 Apr 14; 179():179-87. PubMed ID: 21284953
    [Abstract] [Full Text] [Related]

  • 27. Lesions of the ventral hippocampus, but not the dorsal hippocampus, impair conditioned fear expression and inhibitory avoidance on the elevated T-maze.
    Trivedi MA, Coover GD.
    Neurobiol Learn Mem; 2004 May 14; 81(3):172-84. PubMed ID: 15082019
    [Abstract] [Full Text] [Related]

  • 28. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
    Albrechet-Souza L, Oliveira AR, De Luca MC, Tomazini FM, Santos NR, Brandão ML.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May 14; 29(4):571-9. PubMed ID: 15866360
    [Abstract] [Full Text] [Related]

  • 29. Modulation of ethanol state-dependent learning by dorsal hippocampal NMDA receptors in mice.
    Rezayof A, Sharifi K, Zarrindast MR, Rassouli Y.
    Alcohol; 2008 Dec 14; 42(8):667-74. PubMed ID: 18774674
    [Abstract] [Full Text] [Related]

  • 30. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze.
    Zanoveli JM, Netto CF, Guimarães FS, Zangrossi H.
    Peptides; 2004 Nov 14; 25(11):1935-41. PubMed ID: 15501525
    [Abstract] [Full Text] [Related]

  • 31. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam.
    Albrechet-Souza L, Cristina de Carvalho M, Rodrigues Franci C, Brandão ML.
    Horm Behav; 2007 Aug 14; 52(2):267-73. PubMed ID: 17553501
    [Abstract] [Full Text] [Related]

  • 32. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior.
    Zarrindast MR, Babapoor-Farrokhran S, Babapoor-Farrokhran S, Rezayof A.
    Life Sci; 2008 Jun 06; 82(23-24):1175-81. PubMed ID: 18456284
    [Abstract] [Full Text] [Related]

  • 33. Activity in prelimbic cortex is required for adjusting the anxiety response level during the elevated plus-maze retest.
    Stern CA, Do Monte FH, Gazarini L, Carobrez AP, Bertoglio LJ.
    Neuroscience; 2010 Sep 29; 170(1):214-22. PubMed ID: 20620194
    [Abstract] [Full Text] [Related]

  • 34. The effects of histaminergic agents in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety.
    Zarrindast MR, Torabi M, Rostami P, Fazli-Tabaei S.
    Pharmacol Biochem Behav; 2006 Nov 29; 85(3):500-6. PubMed ID: 17109942
    [Abstract] [Full Text] [Related]

  • 35. Amphetamine and pentylenetetrazole given post-trial 1 enhance one-trial tolerance to the anxiolytic effect of diazepam in the elevated plus-maze in mice.
    Vargas KM, Da Cunha C, Andreatini R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec 30; 30(8):1394-402. PubMed ID: 16828217
    [Abstract] [Full Text] [Related]

  • 36. Involvement of hippocampal metabotropic glutamate receptors in radial maze performance.
    Hayashi K, Yoshihara T, Ichitani Y.
    Neuroreport; 2007 May 07; 18(7):719-23. PubMed ID: 17426606
    [Abstract] [Full Text] [Related]

  • 37. The amygdala and emotional modulation of competition between cognitive and habit memory.
    Wingard JC, Packard MG.
    Behav Brain Res; 2008 Nov 03; 193(1):126-31. PubMed ID: 18565602
    [Abstract] [Full Text] [Related]

  • 38. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM, Canto-de-Souza A.
    Brain Res; 2008 Sep 22; 1231():93-102. PubMed ID: 18621039
    [Abstract] [Full Text] [Related]

  • 39. The role of CA3 GABAA receptors on anxiolytic-like behaviors and avoidance memory deficit induced by NMDA receptor antagonists.
    Zarrabian S, Farahizadeh M, Nasehi M, Zarrindast MR.
    J Psychopharmacol; 2016 Feb 22; 30(2):215-23. PubMed ID: 26755545
    [Abstract] [Full Text] [Related]

  • 40. Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray.
    Lima VC, Molchanov ML, Aguiar DC, Campos AC, Guimarães FS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):178-85. PubMed ID: 17804134
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.